Drugs

Jun 22, 2024, 14:35

FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer

FDA Oncology shared on X:

“FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer.”

Source: FDA Oncology/X

Adagrasib cancer cetuximab colorectal cancer FDA FDA Oncology Headlines KRAS OncoDaily Oncology

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Blog Posts

Aug 18, 2025, 20:57

Niranjala Siriwardena: Why I’m Fighting for Australia’s First Workplace Cancer Survivorship Policy

Voices

Aug 18, 2025, 20:47

Wafaa M Rashed: Final Words to the Tenth Cohort of the Policy Advocacy in Genetics and Genomics Course

Blog Posts

Aug 18, 2025, 20:36

Gashaw Arega: The Beginning of Childhood Cancer Care in Ethiopia

Opinion

Aug 18, 2025, 20:22

Soumen Das: From LMIC to LRS - Rethinking Global Health

Health Policy

Aug 18, 2025, 20:12

Niranjala Siriwardena: Building Australia’s First Workplace Cancer Survivorship Policy

Voices

Aug 18, 2025, 20:02

Confronting Stigma at the Crossroads of Hepatitis and Cancer - European Cancer Organisation

Positive

Aug 18, 2025, 19:53

Erin and Chloe Raise £800 for Lung Cancer Research - Oncogene Cancer Research

Blog Posts

Aug 18, 2025, 19:28

Liz O’Riordan: Everything You Need to Know about Breast Cancer Recurrence

Blog Posts

Aug 18, 2025, 19:17

Matteo Bauckneht: Pitfalls in PSMA-Based RLT - A Case-Based Review at EANM25

Insight

Aug 18, 2025, 18:55

NCODA Brings the BREAKWATER Trial into Practice

Blog Posts

Aug 18, 2025, 18:20

Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025

Insight

Aug 18, 2025, 18:09

Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer